On September 1, 2022, Mr. Gerard van Hamel Platerink informed the Board of Directors of Augmedix, Inc. of his decision to resign as director and Chairman of the Board, including as a member of its Compensation Committee and Chair of its Nominating and Corporate Governance Committee, effectively as of September 2, 2022. Mr. van Hamel Platerink's resignation follows his departure from Redmile Group LLC earlier this year.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -0.81% | -46.07% | -79.49% |
May. 14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
May. 14 | B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.49% | 59.95M | |
+14.77% | 70.15B | |
+5.15% | 17.25B | |
+12.10% | 13.79B | |
+20.33% | 13.61B | |
+16.67% | 10.09B | |
-19.27% | 7.24B | |
-1.18% | 6.2B | |
+3.35% | 5.3B | |
+1.13% | 5.01B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Announces Resignation of Gerard Van Hamel Platerink as Director